Please login to the form below

Not currently logged in
Email:
Password:

PR company appoints new UK head

Chamberlain Healthcare Public Relations has appointed Mark John Cater as managing director of its London office

Chamberlain Healthcare Public Relations, an inVentiv Health company, has appointed Mark John Cater as managing director of its London office.

Prior to joining Chamberlain, Cater was regional director, Europe, Middle East, Africa and India for Cohn & Wolfe, and chief executive officer of GCI UK before the company merged in 2008 with Cohn & Wolfe. He also spent six years in various leadership roles as partner and director at public relations agency Ketchum, where he was responsible for the company's worldwide healthcare practice and served in both the London and New York offices.  

"Given our brief tenure but serious intentions in London, it is important we attract the best leadership," said Richard Chamberlain, the agency's president. "Mark's 22 years of public relations experience in both the public and private sectors across the UK, European and the US markets makes him exceptionally qualified to lead our London team, support our worldwide clients and further our global communications efforts." 

Chamberlain Healthcare Public Relations serves the healthcare sector exclusively. Operating in London since 2008, the firm works on behalf of several US-based, worldwide pharmaceutical clients on their global brands and issues.

 

4th January 2010

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics